Skip to main content
Fig. 2 | Journal of Translational Medicine

Fig. 2

From: LncRNA RP3-525N10.2-NFKB1-PROS1 triplet-mediated low PROS1 expression is an onco-immunological biomarker in low-grade gliomas: a pan-cancer analysis with experimental verification

Fig. 2

mRNA and protein expression of PROS1 in glioma patients. A Immunohistochemical staining of PROS1 was performed in 15 paired tumor samples compared with adjacent normal samples.Scare bars, 50 mM. B Realtive mRNA expression of PROS1 in 30 paired tumor samples compared with adjacent normal samples. C Realtive mRNA expression of PROS1 in 4 cell lines (NHA, U87, U251 and T98G). ***p < 0.001

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us